高级检索
当前位置: 首页 > 详情页

31例原发性中枢神经系统恶性淋巴瘤临床分析

Clinical Studies on Primary Central Nervous System Lymphoma: A Report of 31 Cases

文献详情

资源类型:
机构: [1]Department of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
出处:
ISSN:

关键词: central nervous system lymphoma diagnosis treatment

摘要:
OBJECTIVE To analyze the clinical manifestations,neuroimaging and pathological characteristics of primary central nervous system lymphoma (PCNSL)with a normal immunity,and to explore the methods of treatment and diagnosis.MKTHODS The clinical,laboratory,imaging data and pathological findings and therapeutic efficacy of 31 cases with pathologically proved PCNSL,during a period from July 1995 to June 2006,were analyzed retrospectively.The method of surgery,used in combination with chemotherapy and radiotherapy,was evaluated in 18 cases versus a simple surgical procedure used in 5.Among the total cases,a CHOP regimen was employed in 11 and Teniposide(VM26)plus Semustine (me-CCUN)was used in 7 cases.RESULTS PCNSL had a variety of clinical features,so that its misdiagnosis rate was high.The main clinical findings of PCNSL included intracranial hypertension and(focal)neurologic impairment.No positive result was found in the CSF cellular examination.All of the 31 cases were B-cell lymphoma.Twenty-four of the 31 cases were followed-up.with a follow-up period from 6 to 98 months.The median period of survival ofthegroup who underwent surqery in combination with chemotherapy and radiotherapy was 20 months,while the group with simple surgical therapy was 10 months.CONCLUSION Specific clinical manifestations were usually absent in the patients with PCNSL,giving an uncertain preoperative diagnosis and a poor prognosis.Pathological examination is the only reliable method for a final diagnosis of the disease.The main objective of surgical therapy is to relieve the intracranial hypertension caused by the tumor.Recurrence may occur in a short period following the simple operation.Therefore combined therapy,i.e.surgery plus additional radiotherapy and chemotherapy,should be adopted.This is the key point for extending survival time and improving the quality of life.

语种:
第一作者:
第一作者机构: [1]Department of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
通讯作者:
通讯机构: [1]Department of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号